Worth reading
59In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
783000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
18th Series Stock Acquisition Rights issued through a third-party allotment, with provisions for adjustment of the exercise price and suspension of exercise
Who receives how much783,000Shares
783,000 shares (subject to the suspension designation)
EVO FUND (7,830 stock acquisition rights subject to the suspension designation)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment provision. The adjustment floor is Not disclosed
Number of Stock Acquisition Rights
Total number issued: Not disclosed; subject to the suspension designation: 7,830 rights (783,000 shares); unexercised balance: Not disclosed
Most recent equity financing
4 December 2025: Issuance of the 18th Series Stock Acquisition Rights (see the materials announced on 18 November 2025 for details)
| Item | Details |
|---|---|
| Type of issuance or disposal | 18th Series Stock Acquisition Rights issued through a third-party allotment, with provisions for adjustment of the exercise price and suspension of exercise |
| Number of shares to be issued or disposed of | 783,000 shares (subject to the suspension designation) |
| Intended allottee | EVO FUND (7,830 stock acquisition rights subject to the suspension designation) |
| Exercise price | Subject to an exercise price adjustment provision. The adjustment floor is Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed; subject to the suspension designation: 7,830 rights (783,000 shares); unexercised balance: Not disclosed |
| Most recent equity financing | 4 December 2025: Issuance of the 18th Series Stock Acquisition Rights (see the materials announced on 18 November 2025 for details) |
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.It was decided to designate the suspension pursuant to the third-party allotment agreement with EVO FUND, the allottee of these stock acquisition rights issued on 4 December 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.